MF
RVMDW icon

Magnetar Financial’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Magnetar Financial’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-119,289
Closed -$19.3K – 913
2024
Q4 		$19.3K Hold
119,289
– – ﹤0.01% 586
2024
Q3 		$16.7K Hold
119,289
– – ﹤0.01% 505
2024
Q2 		$8.51K Hold
119,289
– – ﹤0.01% 493
2024
Q1 		$22.2K Hold
119,289
– – ﹤0.01% 352
2023
Q4 		$39.4K Buy
+119,289
New +$53.3K ﹤0.01% 349

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Magnetar Financial's RVMDW Position: Q1 2025 in Review

Magnetar Financial sold out of Revolution Medicines Inc Warrant (RVMDW) in Q1 2025, closing a stake of 119,289 shares — an estimated $19.3K sold.

Magnetar Financial first reported a position in RVMDW in Q4 2023 and held it in 5 quarters. The position peaked at $39.4K in Q4 2023. 24 funds tracked by Wall St. Rank hold RVMDW as of Q1 2025.

  • Magnetar Financial reported no remaining Revolution Medicines Inc Warrant position as of Q1 2025 after selling out during the quarter.
  • Magnetar Financial sold 119,289 Revolution Medicines Inc Warrant shares in Q1 2025, an estimated $19.3K.
  • Magnetar Financial first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and held it in 5 quarters.
  • Magnetar Financial's Revolution Medicines Inc Warrant position peaked at $39.4K in Q4 2023.
  • 24 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.